Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 24,308 | 7,849 | 1,263 | 183 | 0 |
| Cost of Goods | 6,656 | 2,551 | 531 | 62 | 0 |
| Gross Profit | 17,652 | 5,298 | 732 | 121 | 0 |
| Operating Expenses | 21,141 | 11,682 | 12,040 | -13,008 | 27,540 |
| Operating Income | -2,833 | -5,833 | -10,777 | 13,191 | -27,540 |
| Other Income | 414 | 49 | 100 | 175 | 1,277 |
| Pre-tax Income | -2,419 | -5,784 | -10,677 | 13,366 | -26,263 |
| Income Tax | -1,326 | -37 | -775 | 241 | -2,699 |
| Net Income Continuous | -1,093 | -5,747 | -9,902 | 13,125 | -23,564 |
| Net Income Discontinuous | 42,731 | -5,318 | 24,794 | N/A | 38,136 |
| Net Income | $41,638 | $-11,065 | $14,892 | $13,125 | $14,572 |
| EPS Basic Total Ops | 1.25 | -0.34 | 0.45 | 0.40 | 0.45 |
| EPS Basic Continuous Ops | -0.04 | -0.17 | -0.30 | 0.40 | -0.72 |
| EPS Basic Discontinuous Ops | 1.29 | -0.16 | 0.75 | N/A | 1.16 |
| EPS Diluted Total Ops | 1.25 | -0.34 | 0.45 | 0.40 | 0.45 |
| EPS Diluted Continuous Ops | -0.04 | -0.17 | -0.30 | 0.40 | -0.72 |
| EPS Diluted Discontinuous Ops | 1.29 | -0.16 | 0.75 | N/A | 1.16 |
| EPS Diluted Before Non-Recurring Items | -0.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,246 | $-5,281 | $-10,200 | $13,946 | $-26,875 |